Omeprazole Eg

Omeprazole, the active ingredient in Omeprazole Eg, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to manage gastro‑reflux and other acid‑related disorders in adults and children. GNH USA supplies Omeprazole Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Eg is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare tumor. - Helicobacter pylori eradication regimens: used in combination with antibiotics to improve eradication rates.

Omeprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild, transient headache reported in many patients. - Diarrhea: loose stools that usually resolve without intervention. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis associated with antibiotic‑related dysbiosis. - Hypomagnesemia: low magnesium levels that may cause muscle cramps or cardiac arrhythmia. - Fracture risk: long‑term use linked to decreased bone mineral density. - Acute interstitial nephritis: inflammation of kidney interstitium. - Stevens‑Johnson syndrome: rare severe skin reaction. - Hepatotoxicity: elevated liver enzymes indicating liver stress.

When prescribing Omeprazole Eg, clinicians should consider several safety aspects: - Assess renal function: adjust use in patients with severe kidney impairment. - Monitor magnesium levels: long‑term therapy may deplete magnesium. - Evaluate bone health: consider calcium/vitamin D supplementation for prolonged use. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole Eg can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased absorption leading to therapeutic failure. - Ketoconazole: markedly reduced antifungal exposure.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring more frequent monitoring. - Digoxin: higher serum concentrations may occur. - Methotrexate: reduced renal clearance can raise toxicity risk.